ATE534908T1 - Verfahren und verbindungen zur diagnose und behandlung von krebs - Google Patents

Verfahren und verbindungen zur diagnose und behandlung von krebs

Info

Publication number
ATE534908T1
ATE534908T1 AT09167060T AT09167060T ATE534908T1 AT E534908 T1 ATE534908 T1 AT E534908T1 AT 09167060 T AT09167060 T AT 09167060T AT 09167060 T AT09167060 T AT 09167060T AT E534908 T1 ATE534908 T1 AT E534908T1
Authority
AT
Austria
Prior art keywords
cancer
histone
lysine
treatment
methods
Prior art date
Application number
AT09167060T
Other languages
English (en)
Inventor
Roland Schuele
Eric Metzger
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Application granted granted Critical
Publication of ATE534908T1 publication Critical patent/ATE534908T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11013Protein kinase C (2.7.11.13)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT09167060T 2009-08-03 2009-08-03 Verfahren und verbindungen zur diagnose und behandlung von krebs ATE534908T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09167060A EP2282208B1 (de) 2009-08-03 2009-08-03 Verfahren und Verbindungen zur Diagnose und Behandlung von Krebs

Publications (1)

Publication Number Publication Date
ATE534908T1 true ATE534908T1 (de) 2011-12-15

Family

ID=41459776

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09167060T ATE534908T1 (de) 2009-08-03 2009-08-03 Verfahren und verbindungen zur diagnose und behandlung von krebs

Country Status (4)

Country Link
US (1) US20120329854A1 (de)
EP (1) EP2282208B1 (de)
AT (1) ATE534908T1 (de)
WO (1) WO2011015593A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020041691A1 (en) * 2018-08-24 2020-02-27 City Of Hope Oligonucleotide inhibitors of nuclear factor kappa-light-chain-enhancer
PL4070111T3 (pl) * 2019-12-02 2025-02-03 Belgian Volition Srl Zastosowanie wolnych pozakomórkowych nukleosomsów jako biomarkerów
JP7454756B2 (ja) * 2019-12-05 2024-03-25 国立大学法人九州大学 がんを診断するための方法、がん診断用組成物、がん診断用キット、がんの状態を評価する方法、並びにがん予防薬及び/又は治療薬をスクリーニングする方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008071B2 (en) * 1999-11-08 2011-08-30 University Of South Florida Compositions and methods for detecting intracellular glucose and analogs thereof
DK2017621T3 (da) * 2007-07-16 2011-08-29 Universitaetsklinikum Freiburg Fremgangsmåde til at forudsige ondartetheden af prostatakræft ved detektering af ekspressionen af den proteinkinase-C-relaterede kinase, PRK1

Also Published As

Publication number Publication date
EP2282208A1 (de) 2011-02-09
EP2282208B1 (de) 2011-11-23
WO2011015593A1 (en) 2011-02-10
US20120329854A1 (en) 2012-12-27

Similar Documents

Publication Publication Date Title
ATE483705T1 (de) (lh-ind0l-7-yl)-(pyrimidin-2 -yl-amino) methanon derivate und verwandte verbindungen als igf-rl inhibitoren zur behandlung von krebs
MX2012002542A (es) Compuestos y composiciones como inhibidores de cinasa de proteina.
UA107783C2 (en) Isoindoline compounds for use in treating cancer
CL2011001967A1 (es) Compuestos derivados de carboxamida-azaheterociclica sustituida, inhibidores de p70s6k, proceso de preparacion de estos; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias y cancer; kit farmaceutico.
DK1853602T3 (da) Kemiske forbindelser
ATE398613T1 (de) Chemische verbindungen
BRPI0813625A2 (pt) Imidazo-[1,2b]-piridozinas 2,3,7-substituídos para tratamento de doenças mediadas por alzk4 ou alk5
UA102867C2 (uk) Антитіла до cxcr4 та їх застосування у лікуванні раку
MX2012003311A (es) Inhibidores de miristato de moleculas pequeñas contra bcr-abl y metodos de uso.
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
MX2010003685A (es) Analogos de quinolona y metodos relacionados con los mismos.
SG171690A1 (en) Treatment of protein degradation disorders
JO3172B1 (ar) تركيبة وطريقة وتحضير الصفراء الصناعية
CL2008000020A1 (es) Compuestos derivados de 2,4-dianilinopirimidinas sustituidas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y tumores malignos.
MX346950B (es) Reovirus que tienen secuencias modificadas.
MX385354B (es) Sales de xantilio 3,6-disustituidas.
EA200970065A1 (ru) Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
DE602007010447D1 (de) Verwendung von 4,17-beta-dihydroxyandrost-4-en-3-on zur behandlung von krebs
ATE543494T1 (de) Griseofulvin-analoga zur behandlung von krebs durch hemmung von zentrosomaler clusterbildung
MY152018A (en) Indole derivatives as anticancer agents
BR112017005242A2 (pt) composto, composição farmacêutica, e, composto para uso.
NO20090402L (no) Glysintransportor-1-inhibitorer
ATE500236T1 (de) Mit lanthionin verwandte verbindungen zur behandlung entzündlicher krankheiten
CL2012001579A1 (es) Compuestos derivados de (heterociclo-piperidina condensada)-(piperazinil) 1-alcanona o de (heterociclo-pirrolidina condensada)-(piperazinil)-1 alcanona, inhibidores de p75; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades neurodegenerativas, esquizofrenia, entre otras; compuesto intermediario.
ATE534908T1 (de) Verfahren und verbindungen zur diagnose und behandlung von krebs